UK Transparency Hub
← Back

NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals

Awarded by NHS England · to Mercury Pharmaceuticals Limited · 2023-04-24T00:00:00+01:00 · £304,504,000

Description

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. …

Supplier
Mercury Pharmaceuticals Limited
Buyer
NHS England
Value
£304,504,000
Category (CPV)
Pharmaceutical products
Award date
2023-04-24T00:00:00+01:00
Buyer constituency
runcorn-and-helsby

Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.

Loading…
Loading…